SEP 09, 2020 6:00 AM PDT

Microbubbles enhance delivery of chemotherapy drug

New research published in APL Bioengineering reports on a new technology developed by scientists at Tulane University that hopes to improve treatment options for patients with hepatocellular carcinoma. The method, described as gas embolization, uses minuscule vaporized droplets of perfluorocarbon to enhance the precision of drug delivery.  

Photo: Pixabay

"By changing the treatment parameters in this paper, we were able to achieve tumor regression, and by combining our method with chemotherapy, we were able to reduce regrowth following treatment," said author Joseph Bull. "Gas embolization has never been used in patients. Demonstrating that it can induce tumor regression is really new. We're very excited about the work in this paper."

The method of gas chemoembolization offers a less invasive treatment option than the conventionally-used invasive transarterial chemoembolization (TACE), say the authors. By combining vaporized perfluorocarbon, a common organic material made of carbon and fluorine that has many applications in pharmaceuticals, anesthetics, and industrial fluids, with chemotherapy drugs (doxorubicin and tirapazamine), the team successfully blocked blood flow to hepatocellular carcinoma tumors. Doxorubicin was particularly effective when combined with gas embolization, shrinking tumors to 2.9% of their initial size.

The technique works intravenously, with the chemotherapy drugs binding to the surface of the perfluorocarbon liquid. The liquid bubbles act as emissaries, transporting the drug through capillaries without causing blood vessel blockage until they are vaporized. During this process, an external ultrasound is also conducted simultaneously, thus allowing the fluid mechanical interface of the droplet to fall in pressure until the droplet converts entirely into microbubbles.

This method allows the drug to be delivered door to door to the specific site of the tumor. As Eureka Alert reports, “The drug DOX binds to the shell of the droplet, and the medicine becomes available to diffuse into the tumor, while the microbubbles cut off blood supply to the tumor.” The authors continue, concluding: “Overall, gas chemoembolization shows promise as a developmental therapy and merits further study in more complex tumor models.”

Sources: APL Bioengineering, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 07, 2020
Cancer
Immune-Related Genes as Prognostic Biomarkers
AUG 07, 2020
Immune-Related Genes as Prognostic Biomarkers
Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system ...
AUG 11, 2020
Immunology
Study Reveals the Two Sides of an Immune Molecule
AUG 11, 2020
Study Reveals the Two Sides of an Immune Molecule
Scientists have discovered a key protein that regulates the immune system to fight off infections. Fascinatingly, the pr ...
AUG 13, 2020
Clinical & Molecular DX
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
AUG 13, 2020
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
A staggering 1 in 8 women in the U.S. will develop an aggressive form of breast cancer in their lifetime, making it the ...
AUG 21, 2020
Cancer
Firefighters risk greater carcinogenic exposure than previously thought
AUG 21, 2020
Firefighters risk greater carcinogenic exposure than previously thought
New research published in the journal Environment International suggests that firefighters may be more exposed to c ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
OCT 28, 2020
Cancer
Race disparities still exist among patients with lung cancer
OCT 28, 2020
Race disparities still exist among patients with lung cancer
Research published recently in the Journal of Surgical Oncology looks at the disparities in lung cancer treatment a ...
Loading Comments...